Indication
Hemophilia A with Inhibitors
5 clinical trials
5 products
Product
Eptacog alfaClinical trial
A Long-Term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors. A Retrospective Follow-up Assessment to F7HAEM/USA/3/USA and F7HAEM/USA/4/USAStatus: Completed, Estimated PCD: 2011-08-01
Product
ConcizumabClinical trial
Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B With InhibitorsStatus: Active (not recruiting), Estimated PCD: 2021-12-27
Product
Mim8Clinical trial
Open-label, Long-term Safety and Efficacy Study of Mim8 in Participants With Haemophilia A With or Without InhibitorsStatus: Recruiting, Estimated PCD: 2028-06-30
Product
NNC0365-3769Clinical trial
A Multinational, Open-label, Randomised, Controlled Study to Investigate Efficacy and Safety of NNC0365-3769 (Mim8) in Adults and Adolescents With Haemophilia A With or Without InhibitorsStatus: Recruiting, Estimated PCD: 2024-03-11
Clinical trial
Open-label Safety Study in Adults and Adolescents With Haemophilia A With and Without FVIII Inhibitors Switching Directly From Emicizumab Prophylaxis to NNC0365-3769 (Mim8) ProphylaxisStatus: Active (not recruiting), Estimated PCD: 2024-09-09
Product
NNC0365-3769 (Mim8)